Xilio Therapeutics, Inc. - Special Call Transcript
Good afternoon, and welcome to the Xilio Therapeutics Virtual Program Spotlight on XTX301, a tumor-activated IL-12. (Operator Instructions) As a reminder, this program will be recorded and a replay will be made available on the Xilio Therapeutics website following the conclusion of the event.
At this time, I would now like to turn the call over to your host, Stacey Davis, Chief Business Officer at Xilio Therapeutics. Please go ahead, Stacey.
Thank you. Next slide. Hello. Welcome to Xilio Therapeutics Virtual Program Spotlighting XTX301, a tumor-activated engineered IL-12. I'm Stacey Davis, our Chief Business Officer, and I'll be moderating this live presentation.
Before we get started, I would like to remind everyone that statements we make on this webcast will include forward-looking statements. These statements are based upon management's current expectations and beliefs as of December 1, 2022, and they are subject to risks, uncertainties and other factors, including those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
